Join
Live feed
·
INSIDERFilingvia Quantisnow
ALX Oncology Holdings Inc. logo

CHIEF EXECUTIVE OFFICER Lettmann Jason sold $4,304 worth of shares (2,230 units at $1.93), decreasing direct ownership by 0.75% to 294,379 units (SEC Form 4) (for tax liability)

ByQuantisnow·Wall Street's wire, on your screen.
ALXO· ALX Oncology Holdings Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ALXO (ALX Oncology Holdings Inc.) and more on Quantisnow.